FORM 8-K

Company

Protalix BioTherapeutics, Inc.

Filed

September 24, 2009

Period of Report

September 22, 2009

Accession Number

0000950123-09-045770

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →